Marine Pharmacology
A section of Marine Drugs (ISSN 1660-3397).
Section Information
Considering that oceans cover approximately 70% of our planet, there are huge untapped marine resources available for the discovery of future therapeutic applications. For example, several marine drugs have been shown to affect basically all hallmarks of cancer and even to contribute to epigenetic reprogramming, although selected cell signaling pathways remain to be further investigated.
This Section of Marine Drugs aims to provide a comprehensive and advanced publication platform for studies concerning all aspects of marine pharmacology, including approved marine-drug-related reports, the pharmacological characterization of marine compounds or their derivatives, preclinical and clinical pharmacological studies on marine-derived compounds, and the development of marine-derived drugs as well as marine-derived pharmaceutical formulations.
Scope
Compound discovery:
- Discovery and development of marine-derived bioactive compounds
- Discovery of Marine-derived drug leads
- Development of derivatives to enhance biological activity and reduce toxicity
Mechanisms of Action:
- Investigation of the molecular and cellular mechanisms through marine-derived compounds
- Target identification and pathway elucidation
Preclinical and clinical studies:
- Preclinical and clinical research involving marine-derived drugs
- Reports of approved marine-derived drugs
Collaborative reports:
- Reports of interdisciplinary research involving marine biologists, chemists, pharmacologists, biotechnologists, and other
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Advances in Marine-Derived Pigments (Deadline: 31 August 2025)
- Bioactive Compounds from Soft Corals (Deadline: 31 August 2025)
- Isolation, Identification and Applications of Marine Source Polysaccharides and Peptides—2nd Edition (Deadline: 31 August 2025)
- Marine Sulfated Polysaccharides and Their Biomedical Applications (Deadline: 1 September 2025)
- Marine Natural Products and Signaling Pathways, 2nd Edition (Deadline: 15 September 2025)
- Bioactive Specialized Metabolites from Marine Plants (Deadline: 30 September 2025)
- Marine-Derived Bioactive Compounds for Neuroprotection (Deadline: 30 September 2025)
- Marine-Derived Novel Antioxidants (Deadline: 30 September 2025)
- Marine Novel Secondary Metabolites and Potential Immunomodulatory Properties (Deadline: 30 September 2025)
- Discovery of Marine-Derived Anticancer Agents, 2nd Edition (Deadline: 30 September 2025)
- High-Value Compounds from Marine Algae (Deadline: 30 September 2025)
- Antioxidant and Anticancer Activities of Compounds Isolated from Seagrasses and Seaweeds (Deadline: 30 September 2025)
- The Bioactive Potential of Marine-Derived Peptides and Proteins (Deadline: 30 September 2025)
- Research on Marine Compounds and Inflammation (Deadline: 1 October 2025)
- Effects of Marine Natural Products in Brain Health and Metabolic Diseases (Deadline: 15 October 2025)
- Metabolic Regulation Functions and Mechanisms of Marine Bioactive Compounds (Deadline: 15 October 2025)
- Marine Natural Products Against Inflammatory-Based Diseases (Deadline: 31 October 2025)
- Marine Antiparasitic Agents, 2nd Edition (Deadline: 31 October 2025)
- Zebrafish Models in Marine Drug Discovery (Deadline: 31 October 2025)
- Enzyme Inhibitors from Marine Resources, 2nd Edition (Deadline: 31 October 2025)
- Marine-Derived Bioactive Substances and Their Mechanisms of Action (Deadline: 31 October 2025)
- Marine Anti-Inflammatory and Antioxidant Agents, 5th Edition (Deadline: 15 November 2025)
- Pharmacological Potential of Marine Natural Products, 3rd Edition (Deadline: 30 November 2025)
- Marine Natural Products with Immunomodulatory Activity (Deadline: 30 November 2025)
- Marine Natural Products as Anticancer Agents, 4th Edition (Deadline: 30 November 2025)
- Marine Natural Products with Anti-aging Activity (Deadline: 30 November 2025)
- Celebrating the 100th Anniversary of Ocean University of China: Potential Therapeutic Benefits of Marine Novel Natural Products (Deadline: 15 December 2025)
- Marine-Derived Novel Drugs in the Treatment of Alzheimer’s Disease (Deadline: 31 December 2025)
- Chemoinformatics for Marine Drug Discovery (Deadline: 31 December 2025)
- Therapeutic Potential of Phlorotannins (Deadline: 31 December 2025)
- Marine Natural Products as Regulators in Cell Signaling Pathway (Deadline: 15 January 2026)
- Marine Bioactive Agents with Anticancer Potential: Discovery and Molecular Mechanisms (Deadline: 15 January 2026)
- Advanced Analytical Methods for Marine Natural Product Discovery (Deadline: 15 January 2026)
- Omics Approaches in Marine Compound Discovery (Deadline: 15 January 2026)
- Marine Bioactive Compound Discovery Through OSMAC Approach—2nd Edition (Deadline: 31 January 2026)
- Marine-Derived Bioactive Compounds with Potential Applications for Retinal Health (Deadline: 31 January 2026)
- Neuroprotective Effects of the Marine-Derived Compounds (Deadline: 31 January 2026)
- Marine Natural Products as Enzyme Inhibitors (Deadline: 15 February 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
